Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Debonnel

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|September 1, 1990
Domoic acid toxicity. Panel discussion: treatmentJ W Olney, J Teitelbaum, C Pinsky, et al.
Neuropharmacology|July 8, 2000
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the ratJ Béïque, C de Montigny, P Blier, et al.
Neuropharmacology|July 8, 2000
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the ratJ Béïque, C de Montigny, P Blier, et al.
Synapse (New York, N.Y.)|September 28, 2001
Effects of bilateral olfactory bulbectomy on N-methyl-D-aspartate receptor function: autoradiographic and behavioral studies in the ratM Robichaud, V Beauchemin, N Lavoie, et al.
Synapse (New York, N.Y.)|May 26, 1999
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sitesJ C Béïque, C de Montigny, P Blier, et al.
European Journal of Pharmacology|July 21, 1998
Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transportersJ C Béïque, N Lavoie, C de Montigny, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptorF P Monnet, G Debonnel, A Fournier, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptorF P Monnet, A Fournier, G Debonnel, et al.
Clinical Neuropharmacology|January 1, 1992
Sigma ligands and neuropeptide Y selectively potentiate the NMDA response in the rat CA3 dorsal hippocampus: in vivo electrophysiological studiesC de Montigny, F P Monnet, A Fournier, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 16, 2000
Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxineJ C Béïque, P Blier, C de Montigny, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|September 1, 1990
Domoic acid toxicity. Panel discussion: treatmentJ W Olney, J Teitelbaum, C Pinsky, et al.
Neuropharmacology|July 8, 2000
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the ratJ Béïque, C de Montigny, P Blier, et al.
Neuropharmacology|July 8, 2000
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the ratJ Béïque, C de Montigny, P Blier, et al.
Synapse (New York, N.Y.)|September 28, 2001
Effects of bilateral olfactory bulbectomy on N-methyl-D-aspartate receptor function: autoradiographic and behavioral studies in the ratM Robichaud, V Beauchemin, N Lavoie, et al.
Synapse (New York, N.Y.)|May 26, 1999
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sitesJ C Béïque, C de Montigny, P Blier, et al.
European Journal of Pharmacology|July 21, 1998
Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transportersJ C Béïque, N Lavoie, C de Montigny, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptorF P Monnet, G Debonnel, A Fournier, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptorF P Monnet, A Fournier, G Debonnel, et al.
Clinical Neuropharmacology|January 1, 1992
Sigma ligands and neuropeptide Y selectively potentiate the NMDA response in the rat CA3 dorsal hippocampus: in vivo electrophysiological studiesC de Montigny, F P Monnet, A Fournier, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 16, 2000
Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxineJ C Béïque, P Blier, C de Montigny, et al.
Pageof 5